Alonso-Espías, M.; Gorostidi, M.; Gracia, M.; García-Pineda, V.; Diestro, M.D.; Siegrist, J.; Hernández, A.; Zapardiel, I. Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy. J. Pers. Med.2023, 13, 1486.
Alonso-Espías, M.; Gorostidi, M.; Gracia, M.; García-Pineda, V.; Diestro, M.D.; Siegrist, J.; Hernández, A.; Zapardiel, I. Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy. J. Pers. Med. 2023, 13, 1486.
Alonso-Espías, M.; Gorostidi, M.; Gracia, M.; García-Pineda, V.; Diestro, M.D.; Siegrist, J.; Hernández, A.; Zapardiel, I. Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy. J. Pers. Med.2023, 13, 1486.
Alonso-Espías, M.; Gorostidi, M.; Gracia, M.; García-Pineda, V.; Diestro, M.D.; Siegrist, J.; Hernández, A.; Zapardiel, I. Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy. J. Pers. Med. 2023, 13, 1486.
Abstract
The benefit of adjuvant radiotherapy (RT) after radical hysterectomy in patients with cervical cancer remains controversial. The aim of this study was to determine the impact on survival of adjuvant RT according to the Sedlis criteria. Patients with early-stage cervical cancer who underwent radical hysterectomy between 2005 and 2022 at a single tertiary institution were included. A multivariate analysis was performed to determinate if RT was an independent prognostic factor for recurrence or death. We also analyzed whether there was a statistically significant difference in overall survival (OS) between patients who met only one or two Sedlis criteria, depending on whether they received adjuvant RT or not. In this retrospective study 121 patients were included of whom 48(39.7%) received adjuvant RT due to the presence of unfavorable pathological findings. In multivariate analysis, RT was not found to be a statistically significant prognostic factor for OS (p=0.584) or disease-free survival (DFS) (p=0.559). When comparing patients who met one or two Sedlis criteria, there were no statistically significant differences in OS between RT and no adjuvant treatment in either group. Since the selection of patients with cervical cancer eligible for surgery is becoming more accurate, adjuvant RT might not be necessary for patients with intermediate-risk factors.
Public Health and Healthcare, Public Health and Health Services
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.